These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3308076)
21. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Yang DC; Wang F; Elliott RL; Head JF Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801 [TBL] [Abstract][Full Text] [Related]
22. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
23. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras. Volm M; Mattern J Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109 [TBL] [Abstract][Full Text] [Related]
24. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
26. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154 [TBL] [Abstract][Full Text] [Related]
27. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
28. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma. Gong Y; Booser DJ; Sneige N Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420 [TBL] [Abstract][Full Text] [Related]
29. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081 [TBL] [Abstract][Full Text] [Related]
30. The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications. Shackney SE; Pollice AA; Smith CA; Alston L; Singh SG; Janocko LE; Brown KA; Petruolo S; Groft DW; Yakulis R; Hartsock RJ Cancer J Sci Am; 1996; 2(2):106-13. PubMed ID: 9166508 [TBL] [Abstract][Full Text] [Related]
31. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy. Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900 [TBL] [Abstract][Full Text] [Related]
32. Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. Holm C; Rayala S; Jirström K; Stål O; Kumar R; Landberg G J Natl Cancer Inst; 2006 May; 98(10):671-80. PubMed ID: 16705121 [TBL] [Abstract][Full Text] [Related]
33. HDAC6 expression is correlated with better survival in breast cancer. Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975 [TBL] [Abstract][Full Text] [Related]
34. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653 [TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma. O'Hanlon DM; Kiely M; MacConmara M; Al-Azzawi R; Connolly Y; Jeffers M; Keane FB Eur J Surg Oncol; 2002 Mar; 28(2):103-7. PubMed ID: 11884043 [TBL] [Abstract][Full Text] [Related]
36. Expression of p21 ras oncoproteins in human cancers. Tanaka T; Slamon DJ; Battifora H; Cline MJ Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727 [TBL] [Abstract][Full Text] [Related]
37. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295 [TBL] [Abstract][Full Text] [Related]
38. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455 [TBL] [Abstract][Full Text] [Related]
39. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400 [TBL] [Abstract][Full Text] [Related]
40. Postmastectomy electron-beam-rotation irradiation in locally advanced breast cancer prognostic factors of locoregional tumor control. Hehr T; Budach W; Durst I; Glocker S; Classen J; Weinmann M; Christ G; Bamberg M Strahlenther Onkol; 2002 Nov; 178(11):624-32. PubMed ID: 12426673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]